我国治疗良性前列腺增生药物市场分析

目前，良性前列腺增生疾病（BPH）已成为中老年男性健康的一大障碍但BPH的发病机制至今还未阐明，现有的药物仅能缓解BPH的进程，还未发现能有效治疗这一疾病的药物、这一新兴的药物市场已引起全球制药企业的广泛关注。本文分析了BPH的流行病学现状，并对BPH的药物市场进行了分析阐述。随着人口老龄化进程的加快，BPH患病率的升高，BPH患者数量不断增大，相应的治疗药物的需求也将不断上升。

The Market Analysis of the Anti-Benign Prostatic Hyperplasia Drugs in China

The disease of Benign Prostatic Hyperplasia （BPH） has become a major obstacle for the middle-aged men＇s health in recent years. However, the pathogenesis of BPH has not yet been clarified, drugs for treatment can only alleviate the process of BPH. It has not reported that a new drug Invented recently can be used for treating the BPH effectively. This emerging drug market has Attractted wide attention from global pharmaceutical companies. We analyze the status of the epidemiology of BPH, and also the market of BPH drugs in this article. With the acceleration of population aging, BPH prevalence and the number of patients increasing, the corresponding demand for drugs will also be on the rise.